<unk>  is a platelet aggregation inhibitor that is FDA approved for the prophylaxis of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or with peripheral arterial disease (PAD). There is a Black Box Warning for this drug as shown here.  Common adverse reactions include bleeding, anemia.
Vorapaxar
Atopaxar
Etamivan
Zosuquidar
Patiromer
Tasimelteon
Zaleplon
Domiphen